Otsuka Holdings Co., Ltd.

4578.T
Drug Manufacturers - General
2026/02/16 Updated
Market Cap: $36.6B (¥5.6T)
Stock Price: $69.23 (¥10,585)
Exchange Rate: 1 USD = ¥152.91

Notice Regarding Differences in Individual Performance Compared to the Previous Fiscal Year

For the fiscal year ending December 2025, operating revenue was 98,840 million yen, a 16.3% decrease year-over-year, operating income was 82,674 million yen, down 19.7%, and net income attributable to owners of parent was 89,863 million yen, down 15.5%.

Importance:
Page Updated: February 13, 2026
IR Disclosure Date: February 13, 2026

Key Figures

  • Operating Revenue: 98,840 million yen (Year-over-Year △16.3%)
  • Operating Income: 82,674 million yen (Year-over-Year △19.7%)
  • Net Income Attributable to Owners of Parent: 89,863 million yen (Year-over-Year △15.5%)

AI要約

Overview of Performance

For the fiscal year ending December 2025, individual operating revenue was 98,840 million yen, a 16.3% decrease from 118,029 million yen in the previous corresponding period. Operating income declined by 19.7% year-over-year to 82,674 million yen, ordinary income decreased by 19.8% to 84,241 million yen, and net income attributable to owners of parent dropped 15.5% to 89,863 million yen. Net income per share was 169.52 yen, down from 196.52 yen in the previous corresponding period.

Reasons for Differences

In the fiscal year ending December 2025, operating revenue declined compared to the previous period due to a decrease in dividend income received from subsidiaries. Accordingly, operating income, ordinary income, and net income attributable to owners of parent also decreased.

Comparison of Operating Revenue for Fiscal Years 2024 and 2025

Comparison of Operating Income for Fiscal Years 2024 and 2025

Comparison of Ordinary Income for Fiscal Years 2024 and 2025

Comparison of Net Income Attributable to Owners of Parent for Fiscal Years 2024 and 2025

Comparison of Net Income Per Share for Fiscal Years 2024 and 2025

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.